Abstract:Purpose: Osteoarthritis (OA) is a multifactorial disease characterized by loss of articular cartilage. TGFβ is considered as a protective factor against cartilage loss in young cartilage by inducing Smad2/3 phosphorylation via the TGFβ receptor ALK5. Smad2/3 phosphorylation (Smad2/3P) lowers MMP13 expression, and prevents deleterious terminal differentiation of chondrocytes. In contrast to Smad2/3P, Smad1/5 phosphorylation, induced by BMPs but also by TGFβ, is linked to terminal differentiation and MMP13 production. Type I receptors that phosphorylate Smad1/5/8 include ALK1 and ALK3. BMP-9 signals via ALK1 and BMP-2 via ALK3, and both ligands induce enhanced glycosaminoglycan synthesis in young cartilage. BMP2 is induced in damaged cartilage while BMP9 is constitutively present in high concentrations in body fluids. If and how these factors modulate chondroprotective TGFβ signaling is still unclear. Therefore, we analyzed BMP-2 and BMP-9 induced Smad signaling and gene expression in chondrocytes, and studied their interaction with TGFβ. Methods: Primary bovine chondrocytes, isolated from the metacarpophalangeal joint of 2 year old animals, or the human G6 chondrocyte cell line were cultured to near confluency and incubated with TGFβ1, BMP-2, BMP-9 or a combination thereof. Smad phosphorylation kinetics were analyzed by specific Smad2p and Smad1/5p staining of Western blots. Expression patterns of Smad specific response genes: PAI-1 (Smad3 signaling), and ID-1, (Smad1/5 signaling) were analyzed from 0-48h by quantitative real time PCR (qPCR). Biological activity was tested with a CAGA12-luc transcriptional reporter construct that produces luciferase in response to Smad3 signaling. Adenovirally transduced cells (MOI = 5) were serum starved for 8h, and stimulated with growth factors for 20h, and luciferase activity was measured. Results: In primary chondrocytes, both BMP-2 and BMP-9 potently induced Smad1/5 phosphorylation, which peeked after 1 h and lasted up to 3 h. BMP-9 was more potent than BMP-2 in inducing Smad1/5p, as a lower dose of BMP-9 (5 ng/ml BMP-9 versus 15 ng/ml BMP-2) was required to induce maximal phosphorylation after 60 min. Remarkably BMP-9 (5 ng/ml or more) was also capable of inducing Smad2 phosphorylation, whereas BMP-2 (up to 50 ng/ml) was not. BMP-9-induced Smad2 phosphorylation lasted from 1 up to 3 hours. Moreover, in contrast to BMP-2, BMP-9 was also able to rapidly (from 2 up to 24h) induce PAI-1 transcription. Both growth factors potently induced ID-1 expression. Strikingly, co-stimulation of primary chondrocytes with TGFβ (1 ng/ml) and these BMPs revealed an even more remarkable difference between both factors on Western blot. BMP-2 was able to dose-dependently (15-50 ng/ml) inhibit TGFβ-induced Smad2 phosphorylation. On the contrary, BMP-9 dose-dependently (5-25 ng/ml) synergized with TGFβ on Smad2/3 phosphorylation. These results were reflected in biological activity, as luciferase production was increased by 50% after co-stimulation of chondrocytes with BMP-9 and TGFβ compared to TGFβ alone (p<0.01). Conclusions: In young cartilage, both BMPs show a distinct difference in Smad phosphorylation and interaction with TGFβ. Although both BMPs promote matrix synthesis (Glycosaminoglycans production), long term effects of both factors on cartilage will most likely differ due to their different effects on chondroprotective Smad2/3 signaling.

Differential effects of osteogenic protein-1 (BMP-7) on gene expression of BMP and GDF family members during differentiation of the mouse MC615 chondrocyte cells

Stage-dependent effect of TGF-beta1 on chondrogenic differentiation of human embryonic stem cells.

Modulation of BMP-2-Induced Chondrogenic Versus Osteogenic Differentiation of Human Mesenchymal Stem Cells by Cell-Specific Extracellular Matrices

Isolation, Characterization and Investigation of Differentiation Potential of Human Periodontal Ligament Cells and Dental Follicle Progenitor Cells and Their Response to BMP-7 in Vitro

Effects of Cartilage Oligomeric Matrix Protein on Bone Morphogenetic Protein‐2‐induced Differentiation of Mesenchymal Stem Cells

Correlation between ALK-6 (BMPR-IB) distribution and responsiveness to osteogenic protein-1 (BMP-7) in embryonic mouse bone rudiments.

Cartilage-derived morphogenetic proteins and osteogenic protein-1 differentially regulate osteogenesis.

Differential Effects of Bone Morphogenetic Protein 2 and 9 On Chondroprotective Transforming Growth Factor beta Signaling

Transforming growth factor-beta1 supports the rapid morphogenesis of heterotopic endochondral bone initiated by human osteogenic protein-1 via the synergistic upregulation of molecular markers

Gene array analysis of bone morphogenetic protein type I receptor-induced osteoblast differentiation.

Osteoprotegerin promotes the proliferation of chondrocytes and affects the expression of ADAMTS-5 and TIMP-4 through MEK/ERK signaling

Prostaglandin E2 inhibits BMP signaling and delays chondrocyte maturation

Cartilage-derived morphogenetic proteins induce osteogenic gene expression in the C2C12 mesenchymal cell line

[Effects of Bone Morphogenetic Protein-2 on Cartilage Oligomeric Matrix Protein Expression in Chondrocytes].

Effect of osteogenic growth peptide on gene expression changes in bone mesenchymal stem cells of OPG~(-/-) mice:A Microarray analysis

Bmp-4 Induction Of Arrest And Differentiation Of Osteoblast-Like Cells Via P21(Cip1) And P27(Kip1) Regulation

Effect of Synthetic Osteogenic Growth Peptide on Proliferation and Differentiation of OPG-/- BMSCs in Different Serum Concentration

Subtle differences in the mitogenic effects of recombinant human bone morphogenetic proteins −2 to −7 on DNA synthesis on primary bone-forming cells and identification of BMP-2/4 receptor

Wnt-mediated regulation of chondrocyte maturation: modulation by TGF-beta.

[Effects of Integrin Metalloproteinases on Osteogenic Differentiation].

The high affinity ALK1-ligand BMP9 induces a hypertrophy-like state in chondrocytes that is antagonized by TGFβ1.